PENETREX Drug Patent Profile
✉ Email this page to a colleague
When do Penetrex patents expire, and what generic alternatives are available?
Penetrex is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in PENETREX is enoxacin. There are three drug master file entries for this compound. Additional details are available on the enoxacin profile page.
Summary for PENETREX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Patent Applications: | 4,059 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PENETREX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PENETREX
US Patents and Regulatory Information for PENETREX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | PENETREX | enoxacin | TABLET;ORAL | 019616-004 | Dec 31, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | PENETREX | enoxacin | TABLET;ORAL | 019616-005 | Dec 31, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PENETREX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | PENETREX | enoxacin | TABLET;ORAL | 019616-004 | Dec 31, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | PENETREX | enoxacin | TABLET;ORAL | 019616-005 | Dec 31, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | PENETREX | enoxacin | TABLET;ORAL | 019616-004 | Dec 31, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | PENETREX | enoxacin | TABLET;ORAL | 019616-005 | Dec 31, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PENETREX
See the table below for patents covering PENETREX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
India | 158226 | PROCESS FOR THE PREPARATION OF NOVEL NAPTHYRIDINE DERIVATIVES | ⤷ Try a Trial |
Finland | 820466 | ⤷ Try a Trial | |
U.S.S.R. | 1029829 | PROCESS FOR PREPARING DERIVATIVES OF 1,8-NAPHTHIRIDINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | ⤷ Try a Trial |
Norway | 156721 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PENETREX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2344130 | 300884 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: OZENOXACIN; REGISTRATION NO/DATE: ES/H/414/1/DC 20170519 |
2344130 | 2017/038 | Ireland | ⤷ Try a Trial | PRODUCT NAME: OZENOXACIN; NAT REGISTRATION NO/DATE: PA1744/003/001 20170616; FIRST REGISTRATION NO/DATE: ES/H/414/01/DC 20170519 |
2344130 | C201730036 | Spain | ⤷ Try a Trial | PRODUCT NAME: OZENOXACINO; NATIONAL AUTHORISATION NUMBER: 82357-ES/H/0414/001/DC; DATE OF AUTHORISATION: 20170830; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): ES/H/414/01/DC; DATE OF FIRST AUTHORISATION IN EEA: 20170519 |
2344130 | 122017000073 | Germany | ⤷ Try a Trial | PRODUCT NAME: OZENOXACIN; NAT. REGISTRATION NO/DATE: 97303.00.00 20170803; FIRST REGISTRATION: BELGIEN BE509591 20170517 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |